News

Knight Therapeutics Introduces JORNAY PM™ for ADHD Treatment

Knight Therapeutics Introduces JORNAY PM™ for ADHD Treatment

Introducing JORNAY PM™ to the Canadian Market

Knight Therapeutics Inc. (TSX: GUD) has exciting news for families managing Attention-Deficit Hyperactivity Disorder (ADHD) in children aged 6 to 12. The company recently launched JORNAY PM™ (methylphenidate HCI extended-release capsules) in Canada. This innovative product offers a new treatment option designed to improve the management of ADHD symptoms.

Understanding ADHD and Its Impact

Attention-Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder affecting both children and adults. Studies estimate its prevalence at around 5-9% in children and adolescents, and 3-5% in adults. Individuals with ADHD can struggle with inattention, hyperactivity, and impulsivity, challenges that can hinder daily functioning and overall quality of life. Given the ongoing need for adequate symptom management, it's essential to explore new and effective treatments like JORNAY PM™.

What Makes JORNAY PM™ Unique?

What sets JORNAY PM™ apart from other medications is its unique evening dosing regimen. Dr. Doron Almagor, a recognized Child and Adolescent Psychiatrist, emphasizes that managing ADHD effectively involves helping children transition into their day as smoothly as possible. JORNAY PM™ is formulated with an innovative delayed-release technology that ensures a gradual onset of effect at waking. This allows for therapeutic benefits not just at the start of the day, but continuing into the evening as well.

The Benefits of Extended Release

JORNAY PM™ employs a dual-layer system — a delayed-release layer that ensures the active ingredient is released at the right time, followed by an extended-release layer that maintains symptom control throughout the day. This fascinating mechanism allows children to experience relief from ADHD symptoms from morning until evening, making daily tasks and interactions much more manageable.

Market Insights and Demand for ADHD Treatments

With awareness of ADHD growing and the need for effective treatments increasing, the Canadian ADHD market was estimated at approximately $1.25 billion, with the methylphenidate segment growing at a compound annual growth rate (CAGR) exceeding 14% over recent years. Such statistics highlight the ongoing opportunity for innovative solutions like JORNAY PM™ to fulfill unmet medical needs.

Clinical Trial Success

JORNAY PM™ underwent thorough testing in two multicenter, randomized, double-blind, placebo-controlled phase 3 clinical trials. Both studies reported statistically significant improvements in ADHD symptom management upon waking and throughout the day, affirming the product's effectiveness. Results indicated common side effects included insomnia, decreased appetite, and slight increases in blood pressure, which were expected and manageable.

Commitment to ADHD Management and Community

Samira Sakhia, President and CEO of Knight Therapeutics, expressed her enthusiasm about the product launch, stating, "We are excited to introduce JORNAY PM™ to the Canadian market, thereby offering a new and advanced treatment option for ADHD patients and their families." This commitment reflects Knight Therapeutics' dedication to supporting the ADHD community by enhancing daily symptom management.

Conclusion: A Pioneering Step Forward

As ADHD remains a complex condition requiring ongoing care, the introduction of JORNAY PM™ symbolizes a significant step forward for pediatric treatment options in Canada. With this innovative product, Knight Therapeutics is well-positioned to lead the charge in improving the lives of children facing the challenges of ADHD.

Frequently Asked Questions

What is JORNAY PM™?

JORNAY PM™ is an extended-release formulation of methylphenidate designed specifically for managing ADHD symptoms in children aged 6 to 12 years in Canada.

How does JORNAY PM™ work?

This medication utilizes a unique delayed-release technology that provides symptom control starting at waking and continues throughout the evening, enabling better daily management of ADHD.

What are the common side effects of JORNAY PM™?

Common side effects observed in clinical trials include insomnia, decreased appetite, and slight increases in blood pressure.

Why is the launch of JORNAY PM™ significant?

The launch is significant because it provides families with a new treatment option that can significantly improve the management of ADHD, addressing an important medical need in the market.

How can I learn more about Knight Therapeutics?

You can learn more about Knight Therapeutics and their products by visiting their official website at www.knighttx.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Patriot Growth Welcomes Rajeev Jain: Operational Excellence

Updated Category News Views 89

Shifting Gears: Patriot Growth's New Leadership Turn When it comes to tightening the ship and pointing towards uncharted waters, new leadership can be the key. This couldn't be more true for Patriot Growth Insurance Services as they welcome Rajeev Jain aboard as their latest Chief Operating Officer. This move is all about reinforcing their commitment to operational...

Continue Reading
Philanthropy in Focus: Town & Country's Star-Studded Day

Updated Category News Views 53

An Annual Celebration of Generosity Town & Country, marking 180 years of observing the social highs and lows, just wrapped up its 13th Annual Philanthropy Summit at Hearst Tower. This wasn't your run-of-the-mill event where you sit and awkwardly sip bad coffee. When you've got high-profile names like Tory Burch and Russell Wilson in the same room, you know it’s a...

Continue Reading
Multiplier's Data Signals Global Hiring Evolution

Updated Category News Views 23

Shaking Up the Global Hiring Playbook You think you know how hiring works globally? Think again. Based on data from a whopping 38,000 cross-border hires, Multiplier's latest Talent Trends has spilled some hot new beans on how companies are rethinking their talent acquisition strategies. This isn’t just some thumb-twiddling speculation either—it’s grounded in real...

Continue Reading
Microplastics Found in Human Blood: Alarming Evidence

Updated Category News Views 106

An Unsettling Discovery in Our Veins Microplastics in the blood? Yep, you read that right, and it’s not some sci-fi horror story—it’s today’s harsh reality. A riveting report from the likes of the Plastic Pollution Coalition and the Canadian Association of Physicians for the Environment has thrown a bucket of cold water on us. They uncovered microplastics in 96%...

Continue Reading
Greek-Serbian Heads Meet to Prep for 2027 Tourism Expo

Updated Category News Views 15

Breaking Cultural and Business Barriers You ever get that feeling when two neighbors finally decide to have a proper sit-down and hash things out? That's the vibe in Athens today, as Greek and Serbian movers and shakers are gathering to lay the groundwork for EXPO 2027 Belgrade. It's a match that's kinda hard to ignore if you're watching Europe's trade routes—especially...

Continue Reading
Northern.tech Enhances Product Software Control & Security

Updated Category News Views 114

The Evolution of Product Software Management Over in Palo Alto, Northern.tech has just flipped the switch on something pretty significant—component orchestration in their Mender solution. This isn't just your run-of-the-mill software update. They're talking about managing software across the entire system of a connected product. You know, pulling all the strings at...

Continue Reading
Radius Global Rebrands to Unite Infrastructure Investments

Updated Category News Views 0

Changing Gears to Navigate Global Connectivity Alright, buckle up because Radius Global Infrastructure, Inc. is making a move that’ll reshape how they play the digital infrastructure game. As of October 28, 2026, they’ve wrapped APWireless into their fold, waving goodbye to separate identities and hello to a unified brand. If you’ve got a finger in the tech pie,...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 9

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
New Ambulatory Surgery Center in Alabama Breaks Ground

Updated Category News Views 18

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

Continue Reading
Beta Bionics Lawsuit: What Investors Need to Know

Updated Category News Views 43

Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...

Continue Reading

Top 5 Most Recently Viewed Articles

Safe Bulkers (NYSE: SB) Sees 52-Week Low Amid Market Struggles

Updated Category News Views 249

Safe Bulkers (NYSE: SB) Faces Market Challenges In a challenging environment for investors, Safe Bulkers Inc. (NYSE: SB) has witnessed its stock drop to a 52-week low, currently standing at $3.4. This decline highlights the broader issues prevalent in the shipping sector, where shifts in demand and fluctuating shipping rates have placed pressure on many companies,...

Continue Reading
Nebius Group N.V. Sees Stock Decline Amid Mixed Earnings Report

Updated Category News Views 301

Nebius Group N.V. Stock Overview Nebius Group N.V. (NASDAQ: NBIS) recently faced a notable decline in stock prices, which reflects ongoing volatility influenced by mixed earnings reports and concerns regarding shareholder dilution. Currently, investors are taking a closer look at the factors contributing to this week's downturn. Recent Performance Analysis On a recent...

Continue Reading
Celebrating the Opening of a New Corporate Center in Vancouver

Updated Category News Views 158

Grand Opening of the New Corporate Center in Vancouver Lincoln Property Company, a leading global real estate firm, has recently celebrated the grand opening of its new Terminal 1 development. Located on port land along the Columbia River, this mixed-use project marks an exciting new chapter for the Port of Vancouver’s waterfront district. The opening event brought...

Continue Reading
Apple's Exciting Retail Expansion Plans for Saudi Arabia

Updated Category News Views 342

Apple's Strategic Retail Expansion in Saudi Arabia Apple® has announced a significant retail expansion plan for Saudi Arabia, marking a new chapter in its engagement with customers in the region. This exciting initiative will begin with the launch of the Apple Store® online anticipated to take place in the summer of 2025. The online platform will provide customers...

Continue Reading
Understanding Investor Sentiment Surrounding Intel Corp Options

Updated Category News Views 240

What the Current Options Activity Indicates About Intel In recent times, institutional investors have shown a notable inclination toward Intel Corporation (NASDAQ: INTC). This interest is hard to overlook. Our assessment of recent options trading activity sheds light on significant investor movements that suggest anticipation of substantial developments related to Intel....

Continue Reading